Ticker Details
ProKidney Corp. Class A Ordinary Shares
IPO Date:	June 30, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$295.83M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.23 | 5.31%
Avg Daily Range (30 D):	$0.06 | 2.97%
Avg Daily Range (90 D):	$0.08 | 3.48%

Institutional Daily Volume
Avg Daily Volume:	1.42M
Avg Daily Volume (30 D):	.86M
Avg Daily Volume (90 D):	1.17M

Trade Size
Avg Trade Size (Sh.):	207
Avg Trade Size (Sh.) (30 D):	159
Avg Trade Size (Sh.) (90 D):	176

Institutional Trades
Total Institutional Trades:	144
Avg Institutional Trade:	$2.07M
Avg Institutional Trade (30 D):	$.62M
Avg Institutional Trade (90 D):	$1.02M
Avg Institutional Trade Volume:	.52M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.32M
Avg Closing Trade (30 D):	$.62M
Avg Closing Trade (90 D):	$.62M
Avg Closing Volume:	880.02K

News

Nov 6, 2025 @ 4:00 PM ProKidney Presents Full Results from the Phase 2 R... Source: Prokidney Corp.

Jun 21, 2024 @ 10:55 AM Play Likely Earnings Beat With 3 Top-Ranked Stocks... Source: Sanghamitra Saha

Jun 12, 2024 @ 1:35 AM ProKidney Announces Pricing of its Upsized $130 Mi... Source: ProKidney

Jun 10, 2024 @ 8:15 PM ProKidney Announces Proposed $125 Million Public O... Source: ProKidney

Jun 10, 2024 @ 10:30 AM ProKidney Announces Positive Interim REGEN-007 Pha... Source: ProKidney

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS
Diluted EPS
Revenue	$.22M	$.22M	$.23M
Gross Profit
Net Income / Loss	$-35.84M	$-36.97M	$-37.95M
Operating Income / Loss	$-38.54M	$-39.71M	$-41.39M
Cost of Revenue
Net Cash Flow	$10.38M	$-12.87M	$-1.32M
PE Ratio